Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists

Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family, and GLP-1 receptor agonists (RAs) have been introduced as a new class of antidiabetic medications in the past decade. The benefits of GLP-1 RAs are derived from their pleiotropic effects, which include glucose-dependent...

Full description

Bibliographic Details
Main Authors: Yu Mi Kang, Chang Hee Jung
Format: Article
Language:English
Published: Academya Publishing Co. 2016-06-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-31-258.pdf